LEVEL-2: LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF-2
for Pulmonary Hypertension Associated With HFpEF
Sites in Wynnewood, Allentown +43 more locations
Sponsor: Tenax Therapeutics, Inc.
Sex: All·Age: 18 - 85
Code: NCT07288398·Phase 3·Recruiting·Listed Dec 2025